Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
199.00    -3.60 (-1.78%)
Bid:
199.00
Ask:
199.50
Spread: 0.50 (0.251%)
Market Cap: £1.29b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Directorate Change

21 Mar 2022 16:30

RNS Number : 4616F
Ashmore Group PLC
21 March 2022
 

 

Ashmore Group plc

21 March 2022

 

DIRECTORATE CHANGE

 

Ashmore Group plc ("Ashmore" / the "Company") today announces that after more than seven years' service on the Board of Directors (the "Board") of Ashmore, including over three years as Chair, David Bennett will be stepping down both as a Non-Executive Director and Chair of the Company on 20 April 2022. The Board would like to take this opportunity to thank David for his significant contribution during his tenure.

 

After due consideration, the Nominations Committee has concluded that Clive Adamson, who has served as a Non-Executive Director since 2015 and is currently the Senior Independent Director, will succeed David as Chair of the Company and Chair of its Nominations Committee, in addition to continuing as Chair of the Audit and Risk Committee, from 21 April 2022.

 

The appointment of Clive as Chair of the Nominations Committee is subject to regulatory approval from the Financial Conduct Authority. Ashmore is in the process of identifying a successor to assume the role of Chair of the Audit and Risk Committee in order to ensure compliance with the UK Corporate Governance Code.

 

As a consequence of these changes, the structure of the Board Committees with effect from 21 April 2022 will be as follows:

 

Audit and Risk

Remuneration

Nominations

Clive Adamson (Interim Chair)

Helen Beck (Chair)

Clive Adamson (Chair)

Helen Beck

Clive Adamson

Helen Beck

Jennifer Bingham

Jennifer Bingham

Jennifer Bingham

 

Ashmore also announces that Jennifer Bingham will assume the role of Senior Independent Director from 21 April 2022 and Clive will step down from this role with effect from the same date.

 

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

 

For further information please contact:

Ashmore Group plc

Paul Measday

Investor Relations +44 (0)20 3077 6278

 

FTI Consulting

Neil Doyle +44 (0)7771 978 220

Kit Dunford +44 (0) 7717 417 038

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFLFLLXLEBBK
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.